Sponsor Pipeline

David Avigan Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07374029 Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML Acute Myeloid Leukemia Recruiting
NCT06799026 A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in… Multiple Myeloma Recruiting
NCT07377435 DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM Multiple Myeloma Recruiting
Disease Areas
Multiple Myeloma (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when David Avigan's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free